Lantern Pharma
LTRN
LTRN
25 hedge funds and large institutions have $6.5M invested in Lantern Pharma in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
Holders
25
Holding in Top 10
–
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$182K | |
| 2 | +$114K | |
| 3 | +$84.6K | |
| 4 |
PFA
Pathway Financial Advisors
South Burlington,
Vermont
|
+$79K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$77.6K |
Top Sellers
| 1 | -$169K | |
| 2 | -$19.1K | |
| 3 | -$14.6K | |
| 4 |
WWM
Wolff Wiese Magana
Carslbad,
California
|
-$7.52K |
| 5 |
BlackRock
New York
|
-$3.67K |